Human dendritic cell deficiency: the missing ID?
Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency
IRF8 mutations and human dendritic-cell immunodeficiency
The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency
Differential rates of replacement of human dermal dendritic cells and macrophages during hematopoietic stem cell transplantation
Evaluation of treatment outcome in 175 patients with Hodgkin lymphoma aged 60 years or over: the SHIELD study
A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines
Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation
The role of an all-oral chemotherapy containing lomustine (CCNU) in advanced,fs progressive Hodgkin lymphoma: a patient-friendly palliative option which can result in long-term disease control
A population-based cytogenetic study of adults with acute lymphoblastic leukemia
Immunophenotyping of diffuse large B-cell lymphoma (DLBCL) defines multiple sub-groups of germinal centre-like tumours displaying different survival characteristics
Incidence and outcome of patients with diffuse large B cell lymphoma with marrow involvement and preliminary experience of an adult acute lymphoblastic leukemia protocol (NEALL VI) in cyclophosphamide, doxorubicin, vincristine, and prednisolone–rituximab refractory patients
Hodgkin lymphoma in the elderly: a clinical review of treatment and outcome, past, present and future
Enteropathy-associated T-cell lymphoma: epidemiology, clinical features, and current treatment strategies
A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-2
CD31 density is a novel risk factor for patients with B-cell chronic lymphocytic leukaemia
